Skip to content

SmartSite 10016240Recalls & reported problems

BD Switzerland Sàrl · 20mm Vial Access Device · Class 2

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10885403270918), received between Jun 12, 2023 and Jun 12, 2023 — classified as 1 malfunction.

The most frequently reported specific device problem is “Contamination” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Contamination1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 12, 2023Contamination; Contamination

    IT WAS REPORTED BY CUSTOMER THAT THE BD 20MM SMARTSITE VAD-ZYMOGENETICS HAD SOME TYPE OF DEBRIS IN PACKAGING. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "SOME TYPE OF DEBRIS IN PACKAGING".

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17107571 ↗

Other Set, administration, intravascular devices

All Set, administration, intravascular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page